ShiraTronics
Manufacturing · Minnesota, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
9210 Wyoming Ave N Ste 275, Minneapolis,...Phone Number
(844) 228-7330Website
www.shiratronics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About ShiraTronics
ShiraTronics is a privately held medical device company located in Minneapolis. Our seasoned team is working to develop new innovative therapies to combat debilitating chronic migraine disease. We are focused on commercializing novel neuromodulation technologies to treat this large unmet clinical need.Explore more
ShiraTronics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ShiraTronics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once ShiraTronics has new funding data
Earning: See what the market has to say on ShiraTronics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if ShiraTronics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when ShiraTronics launches new products
Check out if ShiraTronics is spiking on competitors!
ShiraTronics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at ShiraTronics
Check if ShiraTronics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to ShiraTronics
Compare insights from companies similar to ShiraTronics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ShiraTronics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ShiraTronics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ShiraTronics.
ShiraTronics financials insights
Gather financial insights about ShiraTronics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Series B
$66M
ShiraTronics Tech Stack
A closer look at the technologies used by ShiraTronics
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Funding
Executive Move
Lateral Move
Executive Move
New Hire
Executive Move
ShiraTronics News & Media
ShiraTronics Announces Positive 12-Month Follow-Up Results from RELIEV-CM Pilot Study, Demonstrating Sustained Clinical Benefit with Investigational Implantable Neuromodulation Therapy for Chronic Migraine
MINNEAPOLIS, Sept. 16, 2025 /PRNewswire/ -- ShiraTronics, Inc., a clinical-stage medical device company focused on developing novel neuromodulation therapies for chronic migraine, today announced compelling 12-month follow-up data from its RELIEV-CM Pilot Study. The findings demonstrate...ShiraTronics chronic migraine treatment demonstrates long-term efficacy
With its pilot study completed, ShiraTronics is now conducting a pivotal trial of its chronic migraine therapy system, with a readout set for 2026.ShiraTronics Initiates IDE Pivotal Study of Implantable Neuromodulation Therapy for Chronic Migraine
First Implants of Innovative Device Completed in the United States and Australia MINNEAPOLIS, Dec. 3, 2024 /PRNewswire/ -- ShiraTronics, a clinical-stage innovator in neuromodulation technology, today announced the initiation of its U.S. Food and Drug Administration (FDA)-approved Investigation Device Exemption (IDE) pivotal trial, the RELIEV-CM2 Clinical Study. The first implants of ShiraTronics neuromodulation therapy for Chronic Migraine have been completed in the United States and Australia,ShiraTronics Raises $66 Million in Oversubscribed Series B Financing to Advance Pioneering Treatment for Chronic Migraine
Implantable Neuromodulation System Shows Early Promise in Improving Patient Quality of Life by Reducing Monthly Headache Days and Severity of Migraine Attacks MINNEAPOLIS, Oct. 9, 2024 /PRNewswire/ -- ShiraTronics, a clinical-stage medical device company developing neurostimulation...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ShiraTronics
Sign Up For FreeTo access detailed company insights
ShiraTronics is a privately held medical device company located in Minneapolis. Our seasoned team is working to develop new innovative therapies to combat debilitating chronic migraine disease. We are focused on commercializing novel neuromodulation technologies to treat this large unmet clinical need.... Read More
